Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 6, Number 3—June 2000
Perspective

A Dynamic Transmission Model for Predicting Trends in Helicobacter pylori and Associated Diseases in the United States

Marcia F.T. Rupnow*Comments to Author , Ross D. Shachter*, Douglas K. Owens*†, and Julie Parsonnet*
Author affiliations: *Stanford University, Stanford, California, USA; †Department of Veterans Affairs Health Care System, Palo Alto, California, USA

Main Article

Table

Input variables and sources

Symbol Description Value Explanation Source
Population parameters
µ_(a) Death rate (per person per year) Age-specific 18
Z Population size (persons) 200,000 Assumption
II Birth rate (persons per year) 2,962 Derived from disease-free
equilibrium simulation
pI Proportion (%) nonsusceptible 20 Based on data from Assumption
developing countries
Disease parameters
pC Proportion (%) of children with 5 Assumption
antrum (vs. corpus) gastritis
pY Proportion (%) of youths with 75 Based on simulation Assumption
antrum (vs. corpus) gastritis
pA Proportion (%) of adults with 95 Assumption
antrum (vs. corpus) gastritis
δ□ 1C AGC to CGC (per person per year) 0 Assumption
___δ□ 1Y AGY to CGY (per person per year) 0 Assumption
___δ□ 1A AGA to CGA (per person per year) 0.0010 1% progression in 10 yrs Assumption
δ□ 2 AGA to DU (per person per year) 0.0046 14% progression in 32 yrs 22
___δ□ 3 DU to CAG (per person per year) 0.0020 2% progression in 10 yrs 15
___δ□ 4 CGA to CAG (per person per year) 0.0112 30% progression in 32 yrs 22
___δ□ 5 CAG to GC (per person per year) 0.0030 3% progression in 10 yrs 13
___ µDU Mortality rate due to DU 0.0050 23
(per person per year)
___ µGU Mortality rate due to GU 0.0100 24
(per person per year)
___ µGC Mortality rate due to GC 0.3219 80% death in 5 yrs 25
(per person per year)

GC = Gastric cancer; DU = Duodenal ulcer; CG = Corpus-predominant gastritis; AG = Antrum-predominant gastritis; CAG = Chronic atrophic gastritis.

Main Article

References
  1. Taylor  DN, Parsonnet  J. Epidemiology and natural history of Helicobacter pylori infection. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, editors. Infections of the gastrointestinal tract. New York: Raven Press; 1995. p. 551-63.
  2. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA. 1994;272:65–9. DOIPubMedGoogle Scholar
  3. Telford  JL, Ghiara  P. Prospects for the development of a vaccine against Helicobacter pylori. Drugs. 1996;52:799–804. DOIPubMedGoogle Scholar
  4. Lee  A. Vaccination against Helicobacter pylori. J Gastroenterol. 1996;31(Suppl 9):69–74. DOIPubMedGoogle Scholar
  5. Parsonnet  J, Blaser  MJ, Perez-Perez  GI, Hargrett-Bean  N, Tauxe  RV. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology. 1992;102:41–6.PubMedGoogle Scholar
  6. Banatvala  N, Mayo  K, Megraud  F, Jennings  R, Deeks  JJ, Feldman  RA. The cohort effect and Helicobacter pylori. J Infect Dis. 1993;168:219–21.PubMedGoogle Scholar
  7. Parsonnet  J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther. 1995;9(Suppl 2):45–51.PubMedGoogle Scholar
  8. Anderson  RM, May  RM. Infectious diseases of humans: dynamics and control. New York: Oxford University Press; 1991.
  9. Kuipers  EJ. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther. 1997;11(Suppl 1):71–88. DOIPubMedGoogle Scholar
  10. Graham  DY. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol. 1991;6:105–13. DOIPubMedGoogle Scholar
  11. Schultze  V, Hackelsberger  A, Günther  T, Miehlke  S, Roessner  A, Malfertheiner  P. Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer disease. Scand J Gastroenterol. 1998;33:137–42. DOIPubMedGoogle Scholar
  12. Sonnenberg  A. Temporal trends and geographical variations of peptic ulcer disease. Aliment Pharmacol Ther. 1995;9(Suppl 2):3–12.PubMedGoogle Scholar
  13. Sipponen  P, Kekki  M, Haapakoski  J, Ihamäki  T, Siurala  M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer. 1985;35:173–7. DOIPubMedGoogle Scholar
  14. Sipponen  P. Helicobacter pylori gastritis--epidemiology. J Gastroenterol. 1997;32:273–7. DOIPubMedGoogle Scholar
  15. Hansson  LE, Nyrén  O, Hsing  AW, Bergström  R, Josefsson  S, Cho  WH, The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335:242–9. DOIPubMedGoogle Scholar
  16. Blaser  MJ, Chyou  PH, Nomura  A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 1995;55:562–5.PubMedGoogle Scholar
  17. Correa  P, Cuello  C, Duque  E, Burbano  LC, Garcia  F, Bolanos  O, Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst. 1976;57:1027–35.PubMedGoogle Scholar
  18. U.S. National Office of Vital Statistics. Abridged life tables--United States, 1950. Vital Statistics--Special Reports 1953;37:333-43.
  19. Gibson  C. Population of the 100 largest cities and other urban places in the United States: 1790 to 1990: U.S. Census Bureau, 1998. Available from: URL: http://www.census.gov/population/www/documentation/twps0027.html.
  20. Feldman  RA, Eccersley  AJ, Hardie  JM. Epidemiology of Helicobacter pylori: acquisition, transmission, population prevalence and disease-to-infection ratio. Br Med Bull. 1998;54:39–53.PubMedGoogle Scholar
  21. Graham  DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology. 1997;113:1983–91. DOIPubMedGoogle Scholar
  22. Valle  J, Kekki  M, Sipponen  P, Ihamäki  T, Siurala  M. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol. 1996;31:546–50. DOIPubMedGoogle Scholar
  23. Bonnevie  O. The incidence of duodenal ulcer in Copenhagen county. Scand J Gastroenterol. 1975;10:385–93.PubMedGoogle Scholar
  24. Bonnevie  O. The incidence of gastric ulcer in Copenhagen county. Scand J Gastroenterol. 1975;10:231–9.PubMedGoogle Scholar
  25. Cancer Statistics Review  SEER. 1973-1995, 1998. Available from: URL: http://www-seer.ims.nci.nih.gov/Publications/CSR7395.
  26. Karnes  WE, Samloff  IM, Siurala  M. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology. 1991;101:167–74.PubMedGoogle Scholar
  27. American Cancer Society. Cancer facts and figures-- 1998. New York: The Society; 1998.
  28. Garfinkel  L. Cancer statistics and trends. In: Murphy GP, Lawrance W Jr, Lenhard RE Jr, editors. American Cancer Society textbook of clinical oncology. Atlanta: American Cancer Society; 1995. p. 1-9.
  29. Susser  M. Causes of peptic ulcer. A selective epidemiologic review. J Chronic Dis. 1967;20:435–56. DOIPubMedGoogle Scholar
  30. Sonnenberg  A. Factors which influence the incidence and course of peptic ulcer. Scand J Gastroenterol Suppl. 1988;155:119–40. DOIPubMedGoogle Scholar
  31. Sonnenberg  A. Geographic and temporal variations in the occurrence of peptic ulcer disease. Scand J Gastroenterol Suppl. 1985;110:11–24. DOIPubMedGoogle Scholar
  32. Kuipers  EJ, Thijs  JC, Festen  HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther. 1995;9(Suppl 2):59–69.PubMedGoogle Scholar
  33. Olshansky  SJ, Carnes  BA. Ever since Gompertz. Demography. 1997;34:1–15. DOIPubMedGoogle Scholar
  34. Kurata  JH, Honda  GD, Frankl  H. The incidence of duodenal and gastric ulcers in a large health maintenance organization. Am J Public Health. 1985;75:625–9. DOIPubMedGoogle Scholar
  35. Hoy  S. Chasing dirt. New York: Oxford University Press; 1995.
  36. Williams  JR, Nokes  DJ, Medley  GF, Anderson  RM. The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes [published erratum appears in Epidemiol Infect 1996 Oct;117:409]. Epidemiol Infect. 1996;116:71–89. DOIPubMedGoogle Scholar
  37. Porco  TC, Blower  SM. Quantifying the intrinsic transmission dynamics of tuberculosis. Theor Popul Biol. 1998;54:117–32. DOIPubMedGoogle Scholar

Main Article

1Specific graphs can be made available to readers upon request.

Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external